跳至主要内容
临床试验/NCT03107481
NCT03107481已完成4 期

Acetaminophen 1g IV vs Hydromorphone 1mg IV for the Treatment of Acute Pain in the Emergency Department

Montefiore Medical Center1 个研究点 分布在 1 个国家目标入组 220 人开始时间: 2017年6月4日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
220
试验地点
1
主要终点
NRS Change at 60 minutes

研究概览

简要总结

The purpose of the current study is to compare the analgesic efficacy of intravenous acetaminophen and intravenous hydromorphone in the treatment of acute pain in the ED.

详细描述

This is a randomized, double-blind placebo-controlled clinical trial comparing intravenous acetaminophen and intravenous hydromorphone in the treatment of acute pain in the Emergency Department. Enrolled subjects presenting to the ED with acute pain will be randomized to receive either acetaminophen 1g IV or hydromorphone 1mg IV.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
21 Years 至 64 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age 21 through 64 years of age: This is a study of adult ED patients.
  • Pain with onset within 7 days: Pain within seven days is the definition of acute pain that has been used in the ED literature.
  • ED attending physician's judgment that the patient's pain warrants IV opioids.
  • ED attending physician's judgment that the patient has capacity to provide informed consent.
  • Patients must be able to understand English or Spanish.

排除标准

  • Use of opioids or tramadol within past 24 hours.
  • Use of acetaminophen or non-steroidal anti-inflammatory medication within the previous 8 hours.
  • Prior adverse reaction to opioids or acetaminophen.
  • Chronic pain syndrome: frequently recurrent or daily pain for at least 3 months results in modulation of pain perception which is thought to be due to down-regulation of pain receptors. Examples of chronic pain syndromes include sickle cell anemia, osteoarthritis, fibromyalgia, and peripheral neuropathies.
  • Medical condition that might affect metabolism or opioid analgesics or acetaminophen such as hepatitis, renal insufficiency or failure, hypo- or hyper-thyroidism, Addison's or Cushing's disease
  • Pregnant or breastfeeding
  • Alcohol intoxication: the presence of alcohol intoxication as judged by the treating physician may alter pain perception.
  • SBP <100 mmHg: Opioids can produce peripheral vasodilation that may result in orthostatic hypotension.
  • HR < 60/min: Opioids can cause bradycardia.
  • Oxygen saturation < 95% on room air: For this study, oxygen saturation must be 95% or above on room air in order to be enrolled.
  • Use of MAO inhibitors in past 30 days: MAO inhibitors have been reported to intensify the effects of at least one opioid drug causing anxiety, confusion and significant respiratory depression or coma.
  • Patients using transdermal pain patches: pain patches may influence both the amount of pain patients report as well as the level of relief they obtain from other treatments.
  • Taking any medication that might interact with one of the study medications, such as SSRI or tricyclic anti-depressants, antipsychotics, anti-malarial medications (quinidine or halofantrine), amiodarone or dronedarone, diphenhydramine, celecoxib, ranitidine, cimetidine, ritanovir, terbinafine or St. John's Wort.
  • Patients who have been previously enrolled in this same study: Patients may only be enrolled once.

研究组 & 干预措施

Acetaminophen

Active Comparator

干预措施: Acetaminophen (Drug)

Hydromorphone

Active Comparator

干预措施: Hydromorphone (Drug)

结局指标

主要结局

NRS Change at 60 minutes

时间窗: 60 minutes

Between group difference in change in NRS pain scores from baseline

次要结局

  • Forego Additional Pain Medication(60 minutes)
  • Receive Rescue Medication(Before 60 minutes)
  • Experience Medication Side Effects(120 Minutes)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Douglas P. Barnaby, MD, MS

Assistant Professor

Montefiore Medical Center

研究点 (1)

Loading locations...

相似试验